Susan's Place Logo

News:

Since its founding in 1995 Susan's Place forums have blossomed into a truly global lifeline. To date we've delivered roughly 1.4 billion page views to hundreds of millions of unique visitors, guided more than 41,000 registered members through 1,985,081 posts and 188,474 topics across 193 boards, and—most importantly—helped save tens of thousands of lives by connecting people to vital information and support at their most vulnerable moments.

Main Menu

Estriol for Multiple Sclerosis

Started by Joann, November 18, 2012, 10:06:27 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

Joann

Synthetic Biologics, Inc. announced today that patient enrollment has been completed in a Phase II clinical trial evaluating the efficacy and safety of Synthetic Biologics' proprietary oral formulation of estriol (Trimesta(TM)) for the treatment of relapsing-remitting multiple sclerosis (MS). With over $8 million in external grant funding awarded to date, this Trimesta clinical trial should be fully funded to its completion.

http://www.msrc.co.uk/index.cfm/fuseaction/show/pageid/1878
♪♫ You dont look different but you have changed...
I'm looking through you,. Your not the same ♪♫ :)
  •